These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 37352228)

  • 1. Evaluation of the rubella surveillance system in South Africa, 2016-2018: A cross-sectional study.
    Gavhi F; De Voux A; Kuonza L; Motaze NV
    PLoS One; 2023; 18(6):e0287170. PubMed ID: 37352228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rubella seroprevalence using residual samples from the South African measles surveillance program: a cross-sectional analytic study.
    Motaze NV; Makhathini L; Smit SB; Adu-Gyamfi CG; Fortuin M; Wiysonge CS; Suchard SM
    Hum Vaccin Immunother; 2020 Nov; 16(11):2656-2662. PubMed ID: 32298204
    [No Abstract]   [Full Text] [Related]  

  • 3. Progress Toward Rubella Elimination - World Health Organization European Region, 2005-2019.
    O'Connor P; Jankovic D; Zimmerman L; Ben Mamou M; Reef S
    MMWR Morb Mortal Wkly Rep; 2021 Jun; 70(23):833-839. PubMed ID: 34111057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Research priorities for accelerating progress toward measles and rubella elimination identified by a cross-sectional web-based survey.
    Kriss JL; Grant GB; Moss WJ; Durrheim DN; Shefer A; Rota PA; Omer SB; Masresha BG; Mulders MN; Hanson M; Linkins RW; Goodson JL
    Vaccine; 2019 Sep; 37(38):5745-5753. PubMed ID: 30898393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology of rubella infection in Cameroon: a 7-year experience of measles and rubella case-based surveillance, 2008-2014.
    Nimpa Mengouo M; Ndze VN; Baonga F; Kobela M; Wiysonge CS
    BMJ Open; 2017 Apr; 7(4):e012959. PubMed ID: 28389483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. When, and how, should we introduce a combination measles-mumps-rubella (MMR) vaccine into the national childhood expanded immunization programme in South Africa?
    Cameron NA
    Vaccine; 2012 Sep; 30 Suppl 3():C58-60. PubMed ID: 22939023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the Measles Surveillance System in Kaduna State, Nigeria (2010-2012).
    Ameh CA; Sufiyan MB; Jacob M; Waziri NE; Olayinka AT
    Online J Public Health Inform; 2016; 8(3):e206. PubMed ID: 28210427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Epidemiologic surveillance of measles and rubella in Campinas (SP), Brazil: the reliability of the data].
    de Barros EN; Silva EM
    Rev Panam Salud Publica; 2006 Mar; 19(3):172-8. PubMed ID: 16640846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Global landscape of measles and rubella surveillance.
    Patel MK; Gibson R; Cohen A; Dumolard L; Gacic-Dobo M
    Vaccine; 2018 Nov; 36(48):7385-7392. PubMed ID: 30318167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of measles and rubella integrated surveillance system in Apulia region, Italy, 3 years after its introduction.
    Turiac IA; Fortunato F; Cappelli MG; Morea A; Chironna M; Prato R; Martinelli D
    Epidemiol Infect; 2018 Apr; 146(5):594-599. PubMed ID: 29532766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A retrospective 5-year review of rubella in South Africa prior to the introduction of a rubella-containing vaccine.
    Hong H; Malfeld S; Smit S; Makhathini L; Fortuin M; Motsamai T; Tselana D; Manamela MJ; Motaze NV; Ntshoe G; Kamupira M; Khosa-Lesola E; Mokoena S; Buthelezi T; Maseti E; Suchard M
    PLoS One; 2022; 17(5):e0265870. PubMed ID: 35512030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Epidemiological surveillance of measles and Germán measles (rubella) within the context of the elimination plan: Colombia, 1995-2009].
    Morón-Duarte LS; Castillo-Pabón JO
    Rev Salud Publica (Bogota); 2012; 14(1):1-14. PubMed ID: 23250311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surveillance and vaccination coverage of measles and rubella in Northern Italy.
    Amendola A; Bubba L; Piralla A; Binda S; Zanetti A; Pariani E; Ranghiero A; Premoli M; Pellegrinelli L; Coppola L; Gramegna M; Baldanti F; Zanetti A
    Hum Vaccin Immunother; 2015; 11(1):206-13. PubMed ID: 25483537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progress Toward Rubella and Congenital Rubella Syndrome Control - South-East Asia Region, 2000-2016.
    Khanal S; Bahl S; Sharifuzzaman M; Dhongde D; Pattamadilok S; Reef S; Morales M; Dabbagh A; Kretsinger K; Patel M
    MMWR Morb Mortal Wkly Rep; 2018 Jun; 67(21):602-606. PubMed ID: 29851943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survey of the perceptions of key stakeholders on the attributes of the South African Notifiable Diseases Surveillance System.
    Benson FG; Musekiwa A; Blumberg L; Rispel LC
    BMC Public Health; 2016 Oct; 16(1):1120. PubMed ID: 27776493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Congenital Rubella Syndrome Surveillance in South Africa Using a Sentinel Site Approach: A Cross-sectional Study.
    Motaze NV; Manamela J; Smit S; Rabie H; Harper K; duPlessis N; Reubenson G; Coetzee M; Ballot D; Moore D; Nuttall J; Linley L; Tooke L; Kriel J; Hallbauer U; Sutton C; Moodley P; Hardie D; Mazanderani AH; Goosen F; Kyaw T; Leroux D; Hussain A; Singh R; Kelly C; Ducasse G; Muller M; Blaauw M; Hamese M; Leeuw T; Mekgoe O; Rakgole P; Dungwa N; Maphosa T; Sanyane K; Preiser W; Cohen C; Suchard M
    Clin Infect Dis; 2019 May; 68(10):1658-1664. PubMed ID: 30203002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progress Toward Measles and Rubella Elimination - India, 2005-2021.
    Murugan R; VanderEnde K; Dhawan V; Haldar P; Chatterjee S; Sharma D; Dzeyie KA; Pattabhiramaiah SB; Khanal S; Sangal L; Bahl S; Tanwar SSS; Morales M; Kassem AM
    MMWR Morb Mortal Wkly Rep; 2022 Dec; 71(50):1569-1575. PubMed ID: 36520657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pediatric sentinel surveillance of vaccine-preventable diseases in Italy.
    Ciofi Degli Atti ML; Salmaso S; Bella A; Arigliani R; Gangemi M; Chiamenti G; Brusoni G; Tozzi AE;
    Pediatr Infect Dis J; 2002 Aug; 21(8):763-8. PubMed ID: 12192166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Global and national laboratory networks support high quality surveillance for measles and rubella.
    Xu W; Zhang Y; Wang H; Zhu Z; Mao N; Mulders MN; Rota PA
    Int Health; 2017 May; 9(3):184-189. PubMed ID: 28582561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progress in measles and rubella elimination in Iran.
    Esteghamati A; Gouya MM; Zahraei SM; Dadras MN; Rashidi A; Mahoney F
    Pediatr Infect Dis J; 2007 Dec; 26(12):1137-41. PubMed ID: 18043452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.